A cancer inhibitor is something that stops cancer from growing, repairing itself or spreading. Cancer growth inhibitors are still a new idea and it is said that cancer inhibition through parp-1 inhibition drugs may be one of the best mechanisms to deal with BRCA1 and BRCA2 cancers of both the ovaries, breasts, stomach and prostates. A cancer inhibitor is not a cancer cure, it is just a way of using a parp antibody or in some case parp antibodies to shrink and reduce tumors.
There are many other enzyme inhibitors in cancer which can be used as a cancer treatment however the new parp drugs BSI201 and Olaparib have returned some pretty impressive results in recent parp clinical trials. The parp inhibitor side effects when being used for cancer inhibition are said to be very low as the drug does not seem to attack healthy cells, just stops the cancerous ones from repairing themselves by changing the hosts DNA.
Other inhibitors in cancer therapy and cancer treatments are:
- Bourtezomib: used to treat people with multiple myeloma, known as a protesome inhibitor.
- Dasatinib used to treat people with chronic myeloid leukemia which stops cancer growing.
- Erlotinib used to treat advanced lung cancer, also known as a tyrosine kinase inhibitor.
- Celfitinib shrinks advanced cancers, also known as a transduction inhibitor.
- Imatinib blocks signals in the cancer cells.
All these cancer growth inhibitors have one thing in common, they all interfere with the cancer cells ability to communicate and repair each other using chemical signals, thus affecting the cancer's ability to develop.